[文献资料]参 考 文 献

CALGB/SWOG 80405：Phase Ⅲ trial of irinotecan / 5-FU/leucovorin（FOLFIRI）or oxaliplatin / 5-FU/leucovorin（mFOLFOX6）with bevacizumab（BV）or cetuximab（CET）for patients（pts）with KRAS wild-type（wt）untreated metastatic adenocarcinoma of the colon or rectum（MCRC）. ......